Advertisement

Topics

Allecra Therapeutics GmbH Company Profile

20:12 EDT 21st March 2019 | BioPortfolio

Allecra Therapeutics
Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections.

Allecra’s Mission
Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving lives of patients whose infections may otherwise may be inadequately treated.

About Allecra Therapeutics
Allecra is a biopharmaceutical company established in 2013 in the European BioValley Life Sciences cluster which is located in the Upper Rhein valley encompassing northwest Switzerland, southeastern Germany and the Alsace Region of France.  Allecra is focussed on the development of novel treatments to combat multi drug-resistant bacterial infections.  The company is based on a strategic partnership between its Founders, Orchid Chemicals and Pharmaceuticals Ltd. (Chennai, India) and its lead investors Forbion Capital Partners and Edmond de Rothschild Investment Partners.  Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving lives of patients whose infections may otherwise may be inadequately treated.

Location

Switzerland
Switzerland
Switzerland
Switzerland
Switzerland
Switzerland

Contact

Phone: +41 79 592 2005
Email: info@allecra.com


News Articles [992 Associated News Articles listed on BioPortfolio]

Beta-Lactamase Inhibitor Pipeline Insights, 2018 Report Featuring Allecra Therapeutics, ...

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Startup 4GENE receives 7-digit Seed-Funding

High-Tech Gründerfonds (HTGF), VC Fonds BW, Mittelständische Beteiligungsgesellschaft Baden-Württemberg GmbH and Goldmann International GmbH have acquired stakes in 4GENE GmbH. The young company, b...

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement

Orchard Therapeutics (NASDAQ:ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovat...

B.R.A.I.N.: Geschäftsjahr 2018-19 - "die Mühe der Ebene"

Frankfurt am Main (www.aktiencheck.de) - B.R.A.I.N.-Aktienanalyse von der EQUI.TS GmbH: Thomas J. Schießle und Daniel Großjohann, Aktienanalysten der EQUI.TS GmbH, bestätigen in einer aktuellen Akt...

Laufende Fusionskontrollverfahren: Bechtle Onsite Services GmbH, Neckarsulm; Erwerb wesentlicher Vermögensteile von der IBM Deutschland Business & Technology Services GmbH, Ehningen, und der IBM Deutschland Customer Support Services GmbH, Berlin

Datum der Anmeldung:11.02.2019Aktenzeichen:B7-41/19Unternehmen:Bechtle Onsite Services GmbH, Neckarsulm; Erwerb wesentlicher Vermögensteile von der IBM Deutschland Business & Technology Services Gm.....

Bayer: Für die Katz!

Bayer hat Haustiere im Blick: Wie der Pharmakonzern am Mittwoch bekannt gab, haben die Tochtergesellschaft "Bayer Animal Health GmbH" und das Biopharma-Unternehmen "NeuroCycle Therapeutics, Inc." (...

Drugs and Medications [42 Associated Drugs and Medications listed on BioPortfolio]

La prairie switzerland [juvena produits de beaute gmbh]

Package.Label Principle Display Panel

Kynamro [kastle therapeutics, llc]

NA

Tobramycin [holopack verpackungstechnik gmbh]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [holopack verpackungstechnik gmbh]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Etoposide [thymoorgan gmbh pharmazir & co. k.g]

Etoposide Injection, USP

PubMed Articles [467 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Clinical Trials [226 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Companies [1840 Associated Companies listed on BioPortfolio]

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’...

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT)...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Isarna Therapeutics GmbH

Isarna Therapeutics has an unmatched commitment to developing TGF-β inhibitors that stimulate the human immune system to effectively fight cancer. Isarna Therapeutics are advancing a unique pip...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "Allecra Therapeutics GmbH" on BioPortfolio

We have published hundreds of Allecra Therapeutics GmbH news stories on BioPortfolio along with dozens of Allecra Therapeutics GmbH Clinical Trials and PubMed Articles about Allecra Therapeutics GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allecra Therapeutics GmbH Companies in our database. You can also find out about relevant Allecra Therapeutics GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record